Practical implementation of automated closed-loop insulin delivery: a French position statement.

[1]  Roman Hovorka,et al.  Training and Support for Hybrid Closed-Loop Therapy , 2020, Journal of diabetes science and technology.

[2]  R. Beck,et al.  A Randomized Trial of Closed-Loop Control in Children with Type 1 Diabetes. , 2020, The New England journal of medicine.

[3]  Jessie J Wong,et al.  Cost, Hassle, and On-Body Experience: Barriers to Diabetes Device Use in Adolescents and Potential Intervention Targets. , 2020, Diabetes technology & therapeutics.

[4]  Janet M. Allen,et al.  Assessing the effect of closed-loop insulin delivery from onset of type 1 diabetes in youth on residual beta-cell function compared to standard insulin therapy (CLOuD study): a randomised parallel study protocol , 2020, BMJ Open.

[5]  R. Slover,et al.  A Clinical Training Program for Hybrid Closed Loop Therapy in a Pediatric Diabetes Clinic , 2020, Journal of diabetes science and technology.

[6]  Janet M. Allen,et al.  What Training, Support, and Resourcing Do Health Professionals Need to Support People Using a Closed-Loop System? A Qualitative Interview Study with Health Professionals Involved in the Closed Loop from Onset in Type 1 Diabetes (CLOuD) Trial , 2020, Diabetes technology & therapeutics.

[7]  A. Haidar,et al.  A Novel Dual-Hormone Insulin-and-Pramlintide Artificial Pancreas for Type 1 Diabetes: A Randomized Controlled Crossover Trial , 2020, Diabetes Care.

[8]  R. Hovorka,et al.  Who Should Access Closed-Loop Technology? A Qualitative Study of Clinician Attitudes in England , 2020, Diabetes technology & therapeutics.

[9]  B. Anderson,et al.  “I'm essentially his pancreas”: Parent perceptions of diabetes burden and opportunities to reduce burden in the care of children <8 years old with type 1 diabetes , 2019, Pediatric diabetes.

[10]  Eyal Dassau,et al.  Six-Month Randomized, Multicenter Trial of Closed-Loop Control in Type 1 Diabetes. , 2019, The New England journal of medicine.

[11]  R. Hovorka,et al.  Fully closed-loop insulin delivery improves glucose control of inpatients with type 2 diabetes receiving hemodialysis. , 2019, Kidney international.

[12]  R. Hovorka,et al.  The importance of prandial insulin bolus timing with hybrid closed‐loop systems , 2019, Diabetic medicine : a journal of the British Diabetic Association.

[13]  Gregory P. Forlenza,et al.  A Clinical Guide to Advanced Diabetes Devices and Closed-Loop Systems Using the CARES Paradigm. , 2019, Diabetes technology & therapeutics.

[14]  Alissa J. Roberts,et al.  Efficacy and Safety of Real Life Usage of MiniMed 670G Automode in Children with Type 1 Diabetes Less than 7 Years Old. , 2019, Diabetes technology & therapeutics.

[15]  F. Doyle,et al.  Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range , 2019, Diabetes Care.

[16]  M. Ladouceur,et al.  Efficacy of Artificial Pancreas Use in Patients With Type 2 Diabetes Using Intensive Insulin Therapy: A Randomized Crossover Pilot Trial , 2019, Diabetes Care.

[17]  Janet M. Allen,et al.  Young Children Have Higher Variability of Insulin Requirements: Observations During Hybrid Closed-Loop Insulin Delivery , 2019, Diabetes Care.

[18]  N. Séjourné,et al.  Revue de la littérature relative au burnout parental. , 2019, Canadian Psychology/Psychologie canadienne.

[19]  Pierre Jallon,et al.  Closed-loop insulin delivery in adults with type 1 diabetes in real-life conditions: a 12-week multicentre, open-label randomised controlled crossover trial. , 2019, The Lancet. Digital health.

[20]  David M Maahs,et al.  State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016-2018. , 2019, Diabetes technology & therapeutics.

[21]  Janet M. Allen,et al.  Home Use of Day-and-Night Hybrid Closed-Loop Insulin Delivery in Very Young Children: A Multicenter, 3-Week, Randomized Trial , 2019, Diabetes Care.

[22]  B. Buckingham,et al.  Safety Evaluation of the MiniMed 670G System in Children 7–13 Years of Age with Type 1 Diabetes , 2019, Diabetes technology & therapeutics.

[23]  D. Maahs,et al.  ISPAD Clinical Practice Consensus Guidelines 2018: Glycemic control targets and glucose monitoring for children, adolescents, and young adults with diabetes , 2018, Pediatric diabetes.

[24]  Janet M. Allen,et al.  Closed-loop insulin delivery in suboptimally controlled type 1 diabetes: a multicentre, 12-week randomised trial , 2018, The Lancet.

[25]  R. Wadwa,et al.  Biopsychosocial Factors Associated With Satisfaction and Sustained Use of Artificial Pancreas Technology and Its Components: a Call to the Technology Field , 2018, Current Diabetes Reports.

[26]  L. Heinemann,et al.  Artificial Pancreas Systems for People With Type 2 Diabetes: Conception and Design of the European CLOSE Project , 2018, Journal of diabetes science and technology.

[27]  A. Hattersley,et al.  Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: a nationwide, register-based cohort study , 2018, The Lancet.

[28]  Roman Hovorka,et al.  Closed‐Loop Insulin Delivery for Glycemic Control in Noncritical Care , 2018, The New England journal of medicine.

[29]  R. Hovorka,et al.  Artificial pancreas treatment for outpatients with type 1 diabetes: systematic review and meta-analysis , 2018, British Medical Journal.

[30]  R. Hovorka,et al.  Day-and-Night Closed-Loop Insulin Delivery in a Broad Population of Pregnant Women With Type 1 Diabetes: A Randomized Controlled Crossover Trial , 2018, Diabetes Care.

[31]  LazaroCaterina,et al.  Automatic Detection and Estimation of Unannounced Meals for Multivariable Artificial Pancreas System , 2018 .

[32]  Lori M Laffel,et al.  Nighttime is the worst time: Parental fear of hypoglycemia in young children with type 1 diabetes , 2018, Pediatric diabetes.

[33]  Eyal Dassau,et al.  Real-Time Detection of Infusion Site Failures in a Closed-Loop Artificial Pancreas , 2018, Journal of Diabetes Science and Technology.

[34]  Eyal Dassau,et al.  Intraperitoneal insulin delivery provides superior glycaemic regulation to subcutaneous insulin delivery in model predictive control‐based fully‐automated artificial pancreas in patients with type 1 diabetes: a pilot study , 2017, Diabetes, obesity & metabolism.

[35]  G. Charpentier,et al.  Practical implementation, education and interpretation guidelines for continuous glucose monitoring: A French position statement. , 2017, Diabetes & Metabolism.

[36]  B. Perkins,et al.  Effect of artificial pancreas systems on glycaemic control in patients with type 1 diabetes: a systematic review and meta-analysis of outpatient randomised controlled trials. , 2017, The lancet. Diabetes & endocrinology.

[37]  Ali Cinar,et al.  Use of Wearable Sensors and Biometric Variables in an Artificial Pancreas System , 2017, Sensors.

[38]  Benyamin Grosman,et al.  Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 Diabetes , 2017, Diabetes technology & therapeutics.

[39]  Roman Hovorka,et al.  Closed-loop insulin delivery in inpatients with type 2 diabetes: a randomised, parallel-group trial. , 2017, The lancet. Diabetes & endocrinology.

[40]  R. Hovorka,et al.  Closed-loop for type 1 diabetes – an introduction and appraisal for the generalist , 2017, BMC Medicine.

[41]  Roman Hovorka,et al.  Closed-Loop Insulin Delivery during Pregnancy in Women with Type 1 Diabetes. , 2016, The New England journal of medicine.

[42]  F. Doyle,et al.  Outcome Measures for Artificial Pancreas Clinical Trials: A Consensus Report , 2016, Diabetes Care.

[43]  Janet M. Allen,et al.  Feasibility of Closed-Loop Insulin Delivery in Type 2 Diabetes: A Randomized Controlled Study , 2014, Diabetes Care.

[44]  K. Reynolds,et al.  Insulin regimens and clinical outcomes in a type 1 diabetes cohort: The SEARCH for Diabetes in Youth study , 2014 .

[45]  E. Renard,et al.  When to treat a diabetic patient using an external insulin pump. Expert consensus. Société francophone du diabète (ex ALFEDIAM) 2009. , 2010, Diabetes & metabolism.

[46]  G. Chrousos,et al.  Effectiveness of artificial pancreas in the non-adult population: A systematic review and network meta-analysis. , 2019, Metabolism: clinical and experimental.

[47]  Y. Jang,et al.  Standards of Medical Care in Diabetes-2010 by the American Diabetes Association: Prevention and Management of Cardiovascular Disease , 2010 .